These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9403093)

  • 1. [Thrombolysis: Reteplase as an innovative alternative].
    Z Kardiol; 1997 Oct; 86(10 Suppl):1-4. PubMed ID: 9403093
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure of the natural plasminogen activator (t-PA) and of reteplase. Controversies on thrombolytic therapy. 45th yearly session of the American College of Cardiology. Orlando, Fla. March 1996].
    Dtsch Med Wochenschr; 1996; 121(36 Suppl Fur Praxis):1-8. PubMed ID: 9401482
    [No Abstract]   [Full Text] [Related]  

  • 3. Reteplase set to enter thrombolytic market.
    Am J Health Syst Pharm; 1997 Jan; 54(1):12. PubMed ID: 9117779
    [No Abstract]   [Full Text] [Related]  

  • 4. Reteplase (Retavase).
    Med Lett Drugs Ther; 1997 Feb; 39(995):17-8. PubMed ID: 9057777
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombolytic therapy].
    Matsuda T
    Nihon Rinsho; 1998 Oct; 56(10):2577-81. PubMed ID: 9796322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial results with a new plasminogen activator.
    Bode C; Peter K; Moser M; Smalling RW; Weaver WD
    Eur Heart J; 1997 Dec; 18 Suppl F():F17-21. PubMed ID: 9447336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the GUSTO trial's main conclusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronaries.
    Eisenberg C
    Pharmacotherapy; 1997; 17(4):850-2. PubMed ID: 9250573
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled trials comparing reteplase with alteplase and streptokinase in patients with acute myocardial infarction.
    Amsterdam EA
    Pharmacotherapy; 1996; 16(5 Pt 2):137S-140S. PubMed ID: 8888101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of thrombolysis: implications for therapy.
    Collen D; Lijnen HR
    Biochem Pharmacol; 1990 Jul; 40(2):177-86. PubMed ID: 2115776
    [No Abstract]   [Full Text] [Related]  

  • 10. Reteplase but not alteplase affects early soluble PECAM-1 and P-selectin release in patients with acute myocardial infarction.
    Gurbel PA; Dalesandro MR; Serebruany VL
    Thromb Haemost; 1998 Oct; 80(4):725. PubMed ID: 9799011
    [No Abstract]   [Full Text] [Related]  

  • 11. Third generation plasminogen activators in the treatment of acute myocardial infarction.
    Talley JD
    J Ark Med Soc; 1996 Apr; 92(11):587-8. PubMed ID: 8675487
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosis.
    Van de Werf F; Jang IK; Collen D
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):91-3. PubMed ID: 2434801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D; Bounameaux H
    Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New thrombolytic agents in myocardial infarction].
    Helft G; Elalamy I; Beygui F; Dambrin G; Lecompte T; Le Pailleur C; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1999 Apr; 92(4):411-7. PubMed ID: 10326149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The results of arterial thrombolysis.
    Kroese AJ; Staxrud LE
    Ann Chir Gynaecol; 1995; 84(4):350-3. PubMed ID: 8687078
    [No Abstract]   [Full Text] [Related]  

  • 16. [Disappointments and trends].
    Heinzl S
    Med Monatsschr Pharm; 1997 Oct; 20(10):263. PubMed ID: 9411176
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fibrinolytic therapy in ischemic brain infarct].
    Del Zoppo GJ; Hacke W
    Dtsch Med Wochenschr; 1987 Apr; 112(15):603-8. PubMed ID: 3104001
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolysis. An approach still on the move.
    Verstraete M
    Drugs; 1989 Feb; 37(2):116-22. PubMed ID: 2495217
    [No Abstract]   [Full Text] [Related]  

  • 19. Reteplase: new preparation. Minimal value: bolus versus infusion.
    Prescrire Int; 1998 Jun; 7(35):73-4. PubMed ID: 10342921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ischemic cardiopathy (VIII). Thrombolysis with plasminogen activator in myocardial infarct].
    Azqueta M; Betriu A
    Rev Esp Cardiol; 1988 Oct; 41(8):491-500. PubMed ID: 3062719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.